Background Use of cell-based medicinal products (CBMPs) represents a state-of-the-art
approach for reducing general immunosuppression in organ transplantation. We tested multiple …

The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) disease (COVID-19)
pandemic has caused millions of deaths worldwide. Genome-wide association studies …

Background. Composite tissue transplantation effectively reconstructs the most complex
defects, but its use is limited because of harmful immunosuppression and the high susceptibility …

We sought to compare neutralising antibody responses between seronaive haemodialysis
patients and the healthy individuals we have already reported on as part of the Legacy study. …

This meeting report from the XV Banff conference describes the creation of a multiorgan
transplant gene panel by the Banff Molecular Diagnostics Working Group (MDWG). This Banff …

The formation of social dominance hierarchies was studied in groups of five juvenile crayfish,
1.3–1.8 cm in length. Animals were grouped together in a small, featureless aquarium after …

Transplantation is the most effective treatment for end-stage organ failure, but organ survival
is limited by immune rejection and the side effects of immunosuppressive regimens. T cells …

Short‐term outcomes in kidney transplantation are marred by progressive transplant failure
and mortality secondary to immunosuppression toxicity. Immune modulation with autologous …

The global community needs to be aware of the potential psychosocial consequences that
may be experienced by health care workers who are actively managing patients with …

Low-dose human interleukin-2 (hIL-2) treatment is used clinically to treat autoimmune
disorders due to the cytokine's preferential expansion of immunosuppressive regulatory T cells (…